PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
29121426-0	2018	Xanthohumol inhibits angiogenesis by suppressing nuclear factor-kappaB activation in pancreatic cancer.	xanthohumol	0-11	nuclear factor kappa B subunit 1	Homo sapiens	49-70	
29121426-4	2018	In this study, we investigated whether xanthohumol inhibited angiogenesis by blocking NF-kappaB activation in pancreatic cancer in vitro and in vivo.	xanthohumol	39-50	nuclear factor kappa B subunit 1	Homo sapiens	86-95	
29121426-5	2018	We initially confirmed that xanthohumol significantly inhibited proliferation and NF-kappaB activation in pancreatic cancer cell lines.	xanthohumol	28-39	nuclear factor kappa B subunit 1	Homo sapiens	82-91	
29121426-10	2018	Taken together, these results showed, for the first time, that xanthohumol inhibited angiogenesis by suppressing NF-kappaB activity in pancreatic cancer.	xanthohumol	63-74	nuclear factor kappa B subunit 1	Homo sapiens	113-122	
19555200-3	2009	The suppression of these cell-mediated immune responses by XN was at, least in part, due to the inhibition of nuclear factor kappa B (NF-kappaB) transcription factor through suppression of phosphorylation of IkappaBalpha, an inhibitor of NF-kappaB.	xanthohumol	59-61	nuclear factor kappa B subunit 1	Homo sapiens	110-132	
19555200-3	2009	The suppression of these cell-mediated immune responses by XN was at, least in part, due to the inhibition of nuclear factor kappa B (NF-kappaB) transcription factor through suppression of phosphorylation of IkappaBalpha, an inhibitor of NF-kappaB.	xanthohumol	59-61	nuclear factor kappa B subunit 1	Homo sapiens	134-143	
19555200-3	2009	The suppression of these cell-mediated immune responses by XN was at, least in part, due to the inhibition of nuclear factor kappa B (NF-kappaB) transcription factor through suppression of phosphorylation of IkappaBalpha, an inhibitor of NF-kappaB.	xanthohumol	59-61	nuclear factor kappa B subunit 1	Homo sapiens	238-247	
17823911-0	2007	AKT/NF-kappaB inhibitor xanthohumol targets cell growth and angiogenesis in hematologic malignancies.	xanthohumol	24-35	nuclear factor kappa B subunit 1	Homo sapiens	4-13	
17823911-2	2007	METHODS: The antiangiogenic Akt/NF-kappaB inhibitor xanthohumol (XN) has in vitro activity against acute and chronic myelogenous leukemia cell lines (AML, CML) and fresh samples from patients were investigated.	xanthohumol	52-63	nuclear factor kappa B subunit 1	Homo sapiens	32-41	
17823911-2	2007	METHODS: The antiangiogenic Akt/NF-kappaB inhibitor xanthohumol (XN) has in vitro activity against acute and chronic myelogenous leukemia cell lines (AML, CML) and fresh samples from patients were investigated.	xanthohumol	65-67	nuclear factor kappa B subunit 1	Homo sapiens	32-41	
34578877-0	2021	Comparison of the Impact of Xanthohumol and Phenethyl Isothiocyanate and Their Combination on Nrf2 and NF-kappaB Pathways in HepG2 Cells In Vitro and Tumor Burden In Vivo.	xanthohumol	28-39	nuclear factor kappa B subunit 1	Homo sapiens	103-112